19 employees
Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy.
2011
$51M
from 3 investors over 3 rounds
Protego Biopharma raised $51M on October 19, 2021
Investors: MPM Capital, Vida Ventures, LLC and Lightspeed Venture Partners